Blood Pressure Program Modestly Reduced New Dementia Cases in Rural China

CATEGORY: DISEASE PREVENTION

Adults with untreated high blood pressure who got extra help bringing it down were about 15% less likely to develop dementia over four years than those given usual care, a large randomized trial in rural China found. Because people were randomly assigned to the two approaches, this design offers stronger evidence than a typical observational study that lowering blood pressure may help protect the brain.¹

326 Villages Randomly Split, 33,995 Adults Enrolled

Researchers enrolled 33,995 adults aged 40 and older who had high blood pressure—a persistent elevation in the force of blood pushing against artery walls—that was not under control. Their 326 villages were randomly split into two groups. In half, trained community health workers helped residents lower their blood pressure with medication and coaching on diet, salt, weight and activity; the other half continued with usual local care. Over four years, the teams tracked new cases of dementia—a lasting loss of memory and thinking ability serious enough to disrupt daily life—using standard memory and daily-function assessments.

Systolic Pressure Fell 22 Points More Than Usual Care

The extra support worked: on average, the intervention group’s top (systolic) blood pressure number fell about 22 points more than in usual care. Alongside that, their risk of developing dementia was roughly 15% lower—a difference unlikely to be due to chance. All-cause dementia was the trial’s prespecified main outcome, the result it was designed to test, and the difference between groups was statistically significant.¹ Serious health problems overall were also slightly less common in the treated group.¹

High Pressure Damages the Brain’s Small Blood Vessels

Years of high pressure quietly damage the small blood vessels that feed the brain, reducing blood flow and contributing to the tiny areas of injury linked to both vascular dementia and Alzheimer’s disease. Keeping pressure closer to a healthy range may ease that strain, which could help explain why the treated group fared better.

Medication Plus Coaching in One Specific Setting

This was a carefully designed trial, so its results carry real weight—but the program combined medication with lifestyle coaching in one specific setting, and it does not tell any one person which treatment is right for them.

28,008 Adults on Blood Pressure Drugs, 13% Lower Odds

Other trial evidence points the same direction, with limits. A pooled analysis of five placebo-controlled trials in 28,008 adults found blood pressure-lowering drugs linked to about 13% lower odds of dementia.² But SPRINT MIND, a large U.S. trial of intensive treatment, found 19% fewer cases of mild cognitive impairment—early memory and thinking trouble that isn’t yet dementia—while its difference in dementia itself could have been due to chance.³

Key Takeaways

• In a large trial, helping adults lower uncontrolled high blood pressure was linked to about 15% fewer cases of dementia over four years.
• The benefit appeared alongside a meaningful drop in blood pressure and came from combining medication with lifestyle support.
• Because participants were randomly assigned to the program or to usual care, this trial offers stronger evidence than an observational study.

References

1. He J, Zhao C, Zhong S, et al. Blood pressure reduction and all-cause dementia in people with uncontrolled hypertension: an open-label, blinded-endpoint, cluster-randomized trial. Nature Medicine. 2025;31(6):2054–2061. link
2. Peters R, Xu Y, Fitzgerald O, et al. Blood pressure lowering and prevention of dementia: an individual patient data meta-analysis. European Heart Journal. 2022;43(48):4980–4990. link.
3. Williamson JD, Pajewski NM, Auchus AP, et al. Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial. JAMA. 2019;321(6):553–561. link.